Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 1 , Pages 15-31, March 2007

Tumour biology and histopathology of neuroendocrine tumours

Department of Pathology, University of Kiel, Michaelisstr. 11, 24105 Kiel, Germany

The tumours of the disseminated/diffuse neuroendocrine cell system are a group of neoplasms sharing uniformly appearing cells which differ from each other in their biology, prognosis and genetics. In the lung they are called carcinoid and small/large-cell neuroendocrine carcinomas. In the gastroenteropancreatic compartment they are classified as well-differentiated neuroendocrine tumours or carcinomas and poorly differentiated neuroendocrine carcinomas. Depending on their localization these neoplasms reveal distinct phenotypes with respect to pathology, immunohistochemistry, and hormonal syndromes. Their clinical behaviour – ranging from benign and low-grade to high-grade malignancy – can be predicted on the basis of clinicopathological criteria. Currently extensive work is being performed to unravel the genetic background.

Key words: neuroendocrine tumours, classification, typing, staging, prognosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(07)00005-X

doi:10.1016/j.beem.2007.01.004

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 1 , Pages 15-31, March 2007